Training activity information
Details
Provide advice on the appropriate use of anti-D in prevention of HDFN
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Differences between routine anti-D prophylaxis and prophylaxis for potentially sensitising events.
- Guidelines relating to anti-D prophylaxis
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 1 |
Outcome
Practice in accordance with antenatal serology standards and guidelines. |
| # 3 |
Outcome
Perform and interpret clinical and laboratory investigations to identify cases of haemolytic disease of the fetus or newborn (HDFN). |
| # 4 |
Outcome
Identify sequential testing algorithms appropriate to the samples under investigation for HDFN. |
| # 5 |
Outcome
Predict current and future pregnancies at highest risk of HDFN. |
| # 6 |
Outcome
Identify and advise healthcare professionals on appropriate actions to manage HDFN. |
| # 7 |
Outcome
Develop management plans including selection of blood components for mother, fetus and neonates during pregnancy. |
| # 8 |
Outcome
Identify actions required in cases of potentially sensitising events during pregnancy. |